Elevated serum α-synuclein autoantibodies in patients with Parkinson’s disease relative to Alzheimer’s disease and controls

Early diagnosis of neurodegenerative diseases is of paramount importance for successful treatment. Lack of sensitive and early biomarkers for diagnosis of diseases like Parkinson’s disease (PD) is a handicapping problem for all movement disorders specialists. Using serum autoimmune antibodies (AI...

Full description

Bibliographic Details
Main Authors: Shalash, Ali, Salama, Mohamed, Makar, Marianne, Roushdy, Tamer, Elrassas, Hannan hany, Mohamed, Wael Mohamed Yousef, ElBalkimy, Mahmoud, Abu Donia, Mohamed
Format: Article
Language:English
English
Published: Frontiers Media S.A. 2017
Subjects:
Online Access:http://irep.iium.edu.my/60803/
http://irep.iium.edu.my/60803/1/Alpha%20Syneculin%20Frontier.pdf
http://irep.iium.edu.my/60803/7/60803_Elevated%20serum_scopus.pdf
_version_ 1848785552611999744
author Shalash, Ali
Salama, Mohamed
Makar, Marianne
Roushdy, Tamer
Elrassas, Hannan hany
Mohamed, Wael Mohamed Yousef
ElBalkimy, Mahmoud
Abu Donia, Mohamed
author_facet Shalash, Ali
Salama, Mohamed
Makar, Marianne
Roushdy, Tamer
Elrassas, Hannan hany
Mohamed, Wael Mohamed Yousef
ElBalkimy, Mahmoud
Abu Donia, Mohamed
author_sort Shalash, Ali
building IIUM Repository
collection Online Access
description Early diagnosis of neurodegenerative diseases is of paramount importance for successful treatment. Lack of sensitive and early biomarkers for diagnosis of diseases like Parkinson’s disease (PD) is a handicapping problem for all movement disorders specialists. Using serum autoimmune antibodies (AIAs) against neural proteins is a new promising strategy to diagnose brain disorders through non-invasive and cost-effective method. In the present study, we measured the level of AIAs against α-synuclein (α-syn), which is an important protein involved in the pathogenesis of PD. In our study patients with PD (46 patients), Alzheimer’s disease (AD) (27 patients) and healthy controls (20 patients) were evaluated according to their sera α-syn AIAs levels. Interestingly, α-syn AIAs were significantly elevated in PD group compared to AD and healthy controls, which advocates their use for diagnosis of PD.
first_indexed 2025-11-14T16:54:58Z
format Article
id iium-60803
institution International Islamic University Malaysia
institution_category Local University
language English
English
last_indexed 2025-11-14T16:54:58Z
publishDate 2017
publisher Frontiers Media S.A.
recordtype eprints
repository_type Digital Repository
spelling iium-608032018-04-20T04:23:39Z http://irep.iium.edu.my/60803/ Elevated serum α-synuclein autoantibodies in patients with Parkinson’s disease relative to Alzheimer’s disease and controls Shalash, Ali Salama, Mohamed Makar, Marianne Roushdy, Tamer Elrassas, Hannan hany Mohamed, Wael Mohamed Yousef ElBalkimy, Mahmoud Abu Donia, Mohamed R Medicine (General) Early diagnosis of neurodegenerative diseases is of paramount importance for successful treatment. Lack of sensitive and early biomarkers for diagnosis of diseases like Parkinson’s disease (PD) is a handicapping problem for all movement disorders specialists. Using serum autoimmune antibodies (AIAs) against neural proteins is a new promising strategy to diagnose brain disorders through non-invasive and cost-effective method. In the present study, we measured the level of AIAs against α-synuclein (α-syn), which is an important protein involved in the pathogenesis of PD. In our study patients with PD (46 patients), Alzheimer’s disease (AD) (27 patients) and healthy controls (20 patients) were evaluated according to their sera α-syn AIAs levels. Interestingly, α-syn AIAs were significantly elevated in PD group compared to AD and healthy controls, which advocates their use for diagnosis of PD. Frontiers Media S.A. 2017-12-22 Article PeerReviewed application/pdf en http://irep.iium.edu.my/60803/1/Alpha%20Syneculin%20Frontier.pdf application/pdf en http://irep.iium.edu.my/60803/7/60803_Elevated%20serum_scopus.pdf Shalash, Ali and Salama, Mohamed and Makar, Marianne and Roushdy, Tamer and Elrassas, Hannan hany and Mohamed, Wael Mohamed Yousef and ElBalkimy, Mahmoud and Abu Donia, Mohamed (2017) Elevated serum α-synuclein autoantibodies in patients with Parkinson’s disease relative to Alzheimer’s disease and controls. Frontiers in Neurology, 8. pp. 1-6. ISSN 1664-2295 https://www.frontiersin.org/articles/10.3389/fneur.2017.00720/full 10.3389/fneur.2017.00720
spellingShingle R Medicine (General)
Shalash, Ali
Salama, Mohamed
Makar, Marianne
Roushdy, Tamer
Elrassas, Hannan hany
Mohamed, Wael Mohamed Yousef
ElBalkimy, Mahmoud
Abu Donia, Mohamed
Elevated serum α-synuclein autoantibodies in patients with Parkinson’s disease relative to Alzheimer’s disease and controls
title Elevated serum α-synuclein autoantibodies in patients with Parkinson’s disease relative to Alzheimer’s disease and controls
title_full Elevated serum α-synuclein autoantibodies in patients with Parkinson’s disease relative to Alzheimer’s disease and controls
title_fullStr Elevated serum α-synuclein autoantibodies in patients with Parkinson’s disease relative to Alzheimer’s disease and controls
title_full_unstemmed Elevated serum α-synuclein autoantibodies in patients with Parkinson’s disease relative to Alzheimer’s disease and controls
title_short Elevated serum α-synuclein autoantibodies in patients with Parkinson’s disease relative to Alzheimer’s disease and controls
title_sort elevated serum α-synuclein autoantibodies in patients with parkinson’s disease relative to alzheimer’s disease and controls
topic R Medicine (General)
url http://irep.iium.edu.my/60803/
http://irep.iium.edu.my/60803/
http://irep.iium.edu.my/60803/
http://irep.iium.edu.my/60803/1/Alpha%20Syneculin%20Frontier.pdf
http://irep.iium.edu.my/60803/7/60803_Elevated%20serum_scopus.pdf